The Medical Letter on Drugs and Therapeutics
FROM
ISSUE 1078
ISSUE 1078
May 15, 2000
Issue 1078
Subscribers: Log in to read full issue. Not a subscriber? Subscribe or purchase issue.
Dofetilide for Atrial Fibrillation
May 15, 2000 (Issue: 1078)
Dofetilide (Tikosyn - Pfizer), a new methanesulfonamide antiarrhythmic drug, has recently been marketed for oral treatment of atrial fibrillation and flutter.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.